OPN expression inhibitor 1

• CAT Number: I043621
• CAS Number: 2257492-95-6
• Molecular Formula: C25H33N3O5
• Molecular Weight: 455.55
• Purity: ≥95%
• Synonyms: 1-benzyl-4-[[(4S,5R,8S,9R,12R,13R)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecan-10-yl]oxymethyl]triazole
• IUPAC Name: 1-benzyl-4-[[(1R,4S,5R,8S,9R,12R,13R)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecan-10-yl]oxymethyl]triazole
• InChI: InChI=1S/C25H33N3O5/c1-16-9-10-21-17(2)22(30-23-25(21)20(16)11-12-24(3,31-23)32-33-25)29-15-19-14-28(27-26-19)13-18-7-5-4-6-8-18/h4-8,14,16-17,20-23H,9-13,15H2,1-3H3/t16-,17-,20+,21+,22?,23-,24-,25-/m1/s1
• InChIKey: QRKZWJMHZFFVGH-UOXUIGFWSA-N
• SMILES: C[C@@H]1CC[C@H]2[C@H](C(O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)OCC5=CN(N=N5)CC6=CC=CC=C6)C

OPN Expression Inhibitor 1（Cat No.:I043621）is a small-molecule compound designed to inhibit the expression of osteopontin (OPN), a protein involved in inflammation, tissue remodeling, and cancer progression. OPN is often overexpressed in various pathological conditions, including cancer, fibrosis, and autoimmune diseases, where it contributes to tumor growth, metastasis, and immune response modulation. By inhibiting OPN expression, this compound aims to reduce disease progression and improve therapeutic outcomes. OPN Expression Inhibitor 1 is being explored for its potential to treat cancers and inflammatory diseases by targeting this key biomarker and therapeutic pathway.